doc. Ing. Pavel Bobáľ, CSc.
přednosta ústavu – Ústav chemických léčiv
korespondenční adresa:
Studentská 832/13, 625 00 Brno
| telefon: | 778 783 287 |
|---|---|
| e‑mail: |
|
| sociální a akademické sítě: |
|---|
Publikace
Počet publikací: 98
2019
-
Development of Atropisomeric Organocatalysts for Asymmetric Henry Reaction
Rok: 2019, druh: Další prezentace na konferencích
-
Development of Atropisomeric Organocatalysts for Asymmetric Henry Reaction
Rok: 2019, druh: Další prezentace na konferencích
-
Genotoxic Effects of Tributyltin and Triphenyltin Isothiocyanates, Cognate RXR Ligands: Comparison in Human Breast Carcinoma MCF 7 and MDA-MB-231 Cells
International Journal of Molecular Sciences, rok: 2019, DOI
-
Investigation of Permeation of Theophylline through Skin Using Selected Piperazine-2,5-Diones
Molecules, rok: 2019, DOI
-
Organocatalyzed asymmetric Henry reaction of fluoroketones
Rok: 2019, druh: Další prezentace na konferencích
-
Parallel in vitro and in silico investigations into anti-inflammatory effects of non-prenylated stilbenoids
Food Chemistry, rok: 2019, ročník: 285, DOI
-
Prenylated Stilbenoids Affect Inflammation by Inhibiting the NF-kappa B/AP-1 Signaling Pathway and Cyclooxygenases and Lipoxygenase
Journal of Natural Products, rok: 2019, ročník: 82, vydání: 7, DOI
-
SAR-mediated Similarity Assessment of the Property Profile for New, Silicon-Based AChE/BChE Inhibitors
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, rok: 2019, DOI
-
Triorganotin derivatives: time-dependent expression of Vimentin, Annexin A5 and selected nuclear receptors mRNA in MDA-MB-231 breast cancer cells
Rok: 2019
-
Triorganotin Isothiocyanates Affect Migration and Immune Check-point Receptors in Human Triple-negative Breast Carcinoma MDA-MB-231 Cells
ANTICANCER RESEARCH, rok: 2019, DOI